CG Oncology (CGON) Other Gross PP&E Adjustments: 2023-2025
Historic Other Gross PP&E Adjustments for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $11.7 million.
- CG Oncology's Other Gross PP&E Adjustments rose 4356.73% to $11.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year increase of 806.31%. This contributed to the annual value of $138,000 for FY2024, which is 132.70% up from last year.
- CG Oncology's Other Gross PP&E Adjustments amounted to $11.7 million in Q3 2025, which was up 1,313.06% from -$965,000 recorded in Q2 2025.
- In the past 5 years, CG Oncology's Other Gross PP&E Adjustments registered a high of $11.7 million during Q3 2025, and its lowest value of -$1.0 million during Q1 2025.
- In the last 3 years, CG Oncology's Other Gross PP&E Adjustments had a median value of -$348,500 in 2024 and averaged $1.1 million.
- The largest annual percentage gain for CG Oncology's Other Gross PP&E Adjustments in the last 5 years was 4,356.73% (2025), contrasted with its biggest fall of 193.31% (2025).
- CG Oncology's Other Gross PP&E Adjustments (Quarterly) stood at -$422,000 in 2023, then spiked by 132.70% to $138,000 in 2024, then surged by 4,356.73% to $11.7 million in 2025.
- Its Other Gross PP&E Adjustments was $11.7 million in Q3 2025, compared to -$965,000 in Q2 2025 and -$1.0 million in Q1 2025.